Clinical and immunoserological status 12 weeks after infection with COVID-19: prospective observational study

Lucía Valiente-De Santis, Inés Pérez-Camacho, Beatriz Sobrino, Gracia Eugenia González, Juan Diego Ruíz-Mesa, Antonio Plata, Ignacio Márquez-Gómez, Marcial Delgado-Fernández, Manuel Castaño, Francisco Oñate, Francisco Orihuela, Begoña Palop, José María Reguera
doi: https://doi.org/10.1101/2020.10.06.20206060

Article Information

doi 
https://doi.org/10.1101/2020.10.06.20206060
History 
  • October 8, 2020.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.

Author Information

  1. Lucía Valiente-De Santis1,2,
  2. Inés Pérez-Camacho1,2,*,
  3. Beatriz Sobrino1,2,
  4. Gracia Eugenia González3,
  5. Juan Diego Ruíz-Mesa1,2,
  6. Antonio Plata1,2,
  7. Ignacio Márquez-Gómez1,2,
  8. Marcial Delgado-Fernández1,2,
  9. Manuel Castaño1,2,
  10. Francisco Oñate1,2,
  11. Francisco Orihuela1,2,
  12. Begoña Palop4 and
  13. José María Reguera1,2
  1. 1IBIMA. Department of Infectious Diseases
  2. 2Regional University Hospital of Málaga. Department of Infectious Diseases
  3. 3Regional University Hospital of Málaga. Department of Pneumology
  4. 4Regional University Hospital of Málaga. Department of Microbiology
  1. ↵*Corresponding author; email: inpercam{at}gmail.com
Back to top
Posted October 08, 2020.
Download PDF
Data/Code
Email
Clinical and immunoserological status 12 weeks after infection with COVID-19: prospective observational study
Lucía Valiente-De Santis, Inés Pérez-Camacho, Beatriz Sobrino, Gracia Eugenia González, Juan Diego Ruíz-Mesa, Antonio Plata, Ignacio Márquez-Gómez, Marcial Delgado-Fernández, Manuel Castaño, Francisco Oñate, Francisco Orihuela, Begoña Palop, José María Reguera
medRxiv 2020.10.06.20206060; doi: https://doi.org/10.1101/2020.10.06.20206060
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area